Stable Istotope Labelled Enokizumab Biosimilar – Anti-IL9 mAb – Research Grade

Reference: PX-TA1254-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Enokizumab Biosimilar - Anti-IL9 mAb - Research Grade
SourceCAS 909875-08-7
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /Synonyms7F3com-2H2,MEDI-528
ReferencePX-TA1254-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-IL9[Homo sapiens] (Enokizumab) Monoclonal Antibody

Enokizumab has been investigated for the treatment of asthma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Enokizumab Biosimilar – Anti-IL9 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below